hanmi pharma jvm inspection machine
Scope
Date
~
-
Korean SMEs
Korea’s SFA Engineering aims for top spot in smart factory market
SFA Engineering Corp., a small South Korean equipment maker, has for decades been known for its automated machines used in the manufacture of displa...
May 09, 2022 (Gmt+09:00)
-
IPOs
Korea’s tough IPO review drives bio startup to Nasdaq
A South Korean bio startup is aiming for a Nasdaq listing, deeming that the country’s exchange sets the bar too high for an initial public off...
Apr 22, 2022 (Gmt+09:00)
-
Artificial intelligence
CJ integrates AI infrastructure and data to launch CJ AI center
CJ Corp. launched an artificial intelligence center Wednesday, which it hopes will lead the conglomerate's digital innovation. The new CJ AI Cente...
Apr 21, 2022 (Gmt+09:00)
-
Bio & Pharma
Boryung takes 'health is wealth' to whole new level – space
South Korean biotech and pharmaceutical companies are expanding their footholds in the global space medicine market. Boryung, formerly Boryung Pharm...
Apr 20, 2022 (Gmt+09:00)
-
Bio & Pharma
FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval
The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi stands out with own drugs as Korean rivals sell imports
South Korea’s Hanmi Pharmaceutical Co. generated sales of more than 1 trillion won ($812.3 million) from its own medicines last year on strong...
Apr 11, 2022 (Gmt+09:00)
-
Korean startups
SaaS provider Clika wants to lead S. Korea's MLOps market
The wider adoption of artificial intelligence around the globe calls for more data in the form of high quality photos, videos, and text. With t...
Apr 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Pharmaceuticals
Samsung Bioepis to double biosimilars, may resume Nasdaq listing plans
Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, plans to double the number of its biosimilar products on sale to 10 by 2025 and acce...
Feb 24, 2022 (Gmt+09:00)
-
Pharmaceuticals
Korean pharma joins global race in RNA therapeutics development
The field of ribonucleic acid (RNA) therapeutics, once considered an unexplored area, is now the most coveted sector in the global biotech industry....
Jan 21, 2022 (Gmt+09:00)
-
Korean chipmakers
Hanmi, other chip machine makers to benefit from TSMC capex hike
Hanmi Semiconductor Co., a chip equipment supplier to global foundry leader Taiwan Semiconductor Manufacturing Co. (TSMC), has posted record profit ...
Jan 20, 2022 (Gmt+09:00)
-
Pharmaceuticals
ABL Bio in $1.06 bn deal with Sanofi for Parkinson's disease treatment
South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...
Jan 12, 2022 (Gmt+09:00)
-
Electronics
Samsung Electronics to open its eco-friendly tech to competitors
LAS VEGAS – Samsung Electronics Co. has announced that it will make its eco-friendly technologies openly available to its competitors as part ...
Jan 06, 2022 (Gmt+09:00)
-
Electronics
LG Display reveals 30% brighter OLED EX
LG Display Co. revealed a 30% brighter OLED panel during Wednesday’s press event. During the media event held in Seoul’s LG Science...
Dec 30, 2021 (Gmt+09:00)
-
Pharmaceuticals
Samsung Biologics wins another Eli Lilly COVID treatment order
Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...
Nov 19, 2021 (Gmt+09:00)
-
M&As
MBK Partners to sell Doosan Machine Tools for $2.1 bn
MBK Partners, a North Asia-focused private equity firm, agreed to sell South Korean Doosan Machine Tools at $2.1 billion to the country’s DTR ...
Aug 13, 2021 (Gmt+09:00)
language -
COVID-19
War for bio talent intensifies as S.Korea works on mRNA vaccines
As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...
Aug 05, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
MBK seeks to exit Japan's top golf course operator
MBK Partners, a North Asia-focused private equity firm, is seeking to exit Japan's largest golf course operator Accordia Next Golf to capitalize on ...
Aug 02, 2021 (Gmt+09:00)
language -
COVID-19
Korea’s pharma consortium to develop mRNA vaccines by 2022
South Korea will develop its own messenger ribonucleic acid (mRNA) vaccines by next year with plans to annually manufacture 100 million doses from 2...
Jun 30, 2021 (Gmt+09:00)
language -
COVID-19
CureVac may pick Korea as Asian base for COVID vaccine production
German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...
Jun 16, 2021 (Gmt+09:00)
language -
COVID-19
Korean pharmas may turn into global vaccine makers on Biden remarks
South Korea’s biosimilar and pharmaceutical companies are looking at a growing chance of emerging as a global hub for manufacturing vaccines f...
May 07, 2021 (Gmt+09:00)
language -
Bio
Korea rises as production hub for coronavirus treatments; darling of global pharmas
South Korea is emerging as a global production base for coronavirus vaccines and medicine thanks to its comprehensive production facilities alongside ...
Sep 15, 2020 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm subsidiary JVM to sell fully automated drug inspection machines in US
Hanmi Pharmaceutical said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug dis...
1 MINUTES AGO